Antithrombotic therapy after cardiac valve surgery: prospective real-world data of Class II guidelines application and outcomes from the EURObservational Research Programme Valvular Heart Disease II survey.

Res Pract Thromb Haemost · 2025 · PMC12419113 · PMID 40933058

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a notable trendP = .09so close (0.05 < p ≤ 0.1)

Additionally, in substudies 1 (ASA use in mechanical prosthesis and concomitant atherosclerotic disease) and 6 (OAC after mitral valve repair), there was also a notable trend toward higher mortality in the non-AT groups at 6 months ( P = .09 and P = .08, respectively).

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.